Beneficial Fungi
Fungi were decomposing rock into soil long before there were nervous systems to soothe. They are not a supplement category. They are the connective tissue of terroir — and, taken inward, they meet the same second terroir we spend our days tending: the gut.
What follows is the modern research record on the fungi people actually ask us about — reishi, cordyceps, lion's mane, turkey tail. Where the evidence is strong we say so. Where it is thin, early, or industry-funded, we say that too.
Spc. 01 — Reishi
Spc. 02 — Cordyceps
Spc. 03 — Lion's mane
Spc. 04 — Turkey tail
The most persistent misreading of medicinal fungi is that their β-glucans are absorbed and act directly on the immune system. Mostly they are not. Fungal polysaccharides are large, poorly absorbed, and reach the colon largely intact, where the microbiota ferments them into short-chain fatty acids — the same acetate, propionate and butyrate that olive polyphenols encourage[6].
Reishi's effect on gut flora has been reviewed directly: its polysaccharides shift community composition and are implicated in its metabolic and anti-inflammatory effects rather than being incidental to them[3]. In practical terms, a mushroom extract is closer to a prebiotic than to a drug.
You do not take the mushroom. You feed the population that reads it, and the population answers your nervous system.
For reishi, the strongest recent synthesis is a 2025 GRADE-assessed systematic review and meta-analysis of clinical trials, which examined nutritional and metabolic outcomes and graded the certainty of each — the honest approach, and rarer than it should be[1]. A separate 2024 meta-analysis of metabolic endpoints in humans reached broadly compatible conclusions[2].
For lion's mane, a 2025 systematic review in Frontiers in Nutrition gathered the benefit and side-effect data together and found the cognition and mood signals promising but underpowered[4]. A broader 2024 review in Neuroscience & Biobehavioral Reviews covered mushrooms and neurocognitive health across the lifespan and reached the same verdict: plausible, patchy, worth testing properly[5]. A registered randomised trial on lion's mane and cognition is recruiting now[7].
For cordyceps, the human literature is thinner than the internet suggests. Cordycepin's pharmacology as an adenosine analogue is well characterised; the translation into durable human outcomes is not[8]. We use it in infusion because of what it does in the gut, not because of a claim we cannot support.
Many products are mycelium grown on a grain substrate and sold whole. The resulting powder can be largely starch, with a β-glucan figure that reflects the grain rather than the fungus. Ask for the fruiting-body fraction and the β-glucan assay, not the 'polysaccharide' number.
A 'polysaccharide' test frequently measures total sugars. Only a specific β-glucan assay distinguishes the fungal compound from the filler.
Trial doses of reishi and lion's mane frequently exceed the amount in a commercial capsule by an order of magnitude. Where the dose is not stated on the label, the trial is not evidence for the product.
Triterpenoids need alcohol; β-glucans need hot water. A single-method extract carries only half the pharmacology it advertises.
None of this is a reason to dismiss fungi. It is the reason to treat them as we treat oil: verified, assayed, and named by species, substrate and dose.
Fungi enter our shelf in one place: the Cordyceps ACV infusion. Acetic acid extraction, live vinegar, no capsule, no proprietary blend. It sits alongside the oils rather than replacing them, because the mechanism is shared — polyphenol and β-glucan meet in the same colon and are read by the same microbiota.
The evidence base for olive polyphenols is far heavier than the one for fungi. We say that openly on the research page, and we will update this page as the trials report.
The nutritional significance of Ganoderma lucidum on human health: a GRADE-assessed systematic review and meta-analysis of clinical trials
Food Science & Nutrition, 2025
Unveiling the metabolic effects of Ganoderma lucidum in humans: a systematic review and meta-analysis
Traditional and Integrative Medicine, 2024
Regulatory effect of Ganoderma lucidum and its active components on gut flora in disease
Frontiers in Microbiology, 2024
Benefits, side effects, and uses of Hericium erinaceus as a supplement: a systematic review
Frontiers in Nutrition, 2025
A review of the effects of mushrooms on mood and neurocognitive health across the lifespan
Neuroscience & Biobehavioral Reviews, 2024
Application of edible fungi in gut microbiota regulation — fungal β-glucans as fermentable substrate and short-chain fatty acid precursor
npj Science of Food, 2025
The impact of supplementation with Hericium erinaceus (lion's mane) on cognition — registered randomised controlled trial, in progress
ClinicalTrials.gov, 2026
Cordyceps militaris and cordycepin: adenosine-analogue pharmacology, exercise tolerance and inflammatory signalling — mechanistic review
Journal of Ethnopharmacology / Phytotherapy literature, 2024–2025
Sources cited by publication and year. This page is reviewed as new trials report. Nothing here is medical advice.